|
|
|
There is a long list of 2174 institutional holders of CVS Health within
the last two holding periods in our database of 13F filers, so we've sorted through to present to you just the top 50 institutional holders of CVS Health by largest
to smallest position reported in the institutional investor's latest 13F filing. In the institutional-holders-of-CVS Health table below,
the initial column indicates the name of each top institutional holder of CVS Health, with a link to that fund's top holdings. The next columns
indicate the amount of CVS Health stock held by each of the institutional holders of CVS Health, followed by the CVS Health position size held by the institution, and finally the
date of the quarterly 13F filing period the holdings data represents for that institution.
Holder | Amount | Position Size
($ in 1000's) | As of |
Vanguard Group Inc. | 117,696,285 | $9,293,299 | 12/31/2023 | CVS | 117,696,285 | $9,293,299 | 12/31/2023 | BlackRock Inc. | 87,022,999 | $6,871,336 | 12/31/2023 | CVS | 87,022,999 | $6,871,336 | 12/31/2023 | Punch & Associates Investment Management Inc. | | $6,596,847 | 12/31/2023 | Call | 83,463 | $6,590,257 | 12/31/2023 | CVS | 83,463 | $6,590 | 12/31/2023 | State Street Corp | 55,203,124 | $4,358,839 | 12/31/2023 | CVS | 55,203,124 | $4,358,839 | 12/31/2023 | Capital World Investors | 40,544,702 | $3,201,410 | 12/31/2023 | CVS | 40,544,702 | $3,201,410 | 12/31/2023 | FMR LLC | 37,818,784 | $2,986,171 | 12/31/2023 | CVS | 37,818,784 | $2,986,171 | 12/31/2023 | Capital International Investors | 33,691,698 | $2,660,298 | 12/31/2023 | CVS | 33,691,698 | $2,660,298 | 12/31/2023 | Morgan Stanley | 30,615,285 | $2,417,383 | 12/31/2023 | CVS | 30,615,285 | $2,417,383 | 12/31/2023 | Dodge & Cox | 30,413,390 | $2,401,441 | 12/31/2023 | CVS | 30,413,390 | $2,401,441 | 12/31/2023 | Geode Capital Management LLC | 24,510,157 | $1,930,435 | 12/31/2023 | CVS | 24,510,157 | $1,930,435 | 12/31/2023 | Invesco Ltd. | 15,960,058 | $1,260,206 | 12/31/2023 | CVS | 15,960,058 | $1,260,206 | 12/31/2023 | Bank of America Corp DE | | $1,211,890 | 12/31/2023 | CVS | 15,256,550 | $1,204,657 | 12/31/2023 | Call | 163,800 | $12,934 | 12/31/2023 | Put | 72,200 | $5,701 | 12/31/2023 | Norges Bank | 13,830,292 | $1,092,040 | 12/31/2023 | CVS | 13,830,292 | $1,092,040 | 12/31/2023 | JPMorgan Chase & Co. | | $1,081,461 | 12/31/2023 | CVS | 13,769,413 | $1,087,233 | 12/31/2023 | Put | 283,500 | $22,385 | 12/31/2023 | Call | 210,400 | $16,613 | 12/31/2023 | Northern Trust Corp | 13,689,459 | $1,080,920 | 12/31/2023 | CVS | 13,689,459 | $1,080,920 | 12/31/2023 | Goldman Sachs Group Inc. | | $1,028,161 | 12/31/2023 | CVS | 12,866,286 | $1,015,922 | 12/31/2023 | Call | 448,900 | $35,445 | 12/31/2023 | Put | 293,900 | $23,206 | 12/31/2023 | Capital Research Global Investors | 12,959,525 | $1,023,284 | 12/31/2023 | CVS | 12,959,525 | $1,023,284 | 12/31/2023 | Charles Schwab Investment Management Inc. | 12,950,289 | $993,351 | 12/31/2023 | CVS | 12,950,289 | $993,351 | 12/31/2023 | Royal Bank of Canada | 12,275,968 | $969,311 | 12/31/2023 | CVS | 12,275,968 | $969,311 | 12/31/2023 | Legal & General Group Plc | 11,802,503 | $931,925 | 12/31/2023 | CVS | 11,802,503 | $931,925 | 12/31/2023 | Price T Rowe Associates Inc. MD | 10,685,766 | $843,749 | 12/31/2023 | CVS | 10,685,766 | $843,749 | 12/31/2023 | Franklin Resources Inc. | 10,565,389 | $834,243 | 12/31/2023 | CVS | 10,565,389 | $834,243 | 12/31/2023 | Bank of New York Mellon Corp | 10,066,101 | $802,872 | 03/31/2024 | CVS | 10,066,101 | $802,872 | 03/31/2024 | Dimensional Fund Advisors LP | 9,744,807 | $769,452 | 12/31/2023 | CVS | 9,744,807 | $769,452 | 12/31/2023 | Nordea Investment Management AB | 8,999,928 | $710,949 | 12/31/2023 | CVS | 8,999,928 | $710,949 | 12/31/2023 | UBS Group AG | | $542,836 | 12/31/2023 | CVS | 7,329,518 | $578,739 | 12/31/2023 | Put | 846,200 | $66,816 | 12/31/2023 | Call | 391,500 | $30,913 | 12/31/2023 | Hotchkis & Wiley Capital Management LLC | 6,696,276 | $528,738 | 12/31/2023 | CVS | 6,696,276 | $528,738 | 12/31/2023 | Deutsche Bank AG | 6,586,239 | $520,049 | 12/31/2023 | CVS | 6,586,239 | $520,049 | 12/31/2023 | Lazard Asset Management LLC | 6,574,342 | $519,107 | 12/31/2023 | CVS | 6,574,342 | $519,107 | 12/31/2023 | UBS Asset Management Americas Inc. | 6,296,150 | $497,144 | 12/31/2023 | CVS | 6,296,150 | $497,144 | 12/31/2023 | LSV Asset Management | 5,964,887 | $470,987 | 12/31/2023 | CVS | 5,964,887 | $470,987 | 12/31/2023 | Macquarie Group Ltd. | 5,639,126 | $445,265 | 12/31/2023 | CVS | 5,639,126 | $445,265 | 12/31/2023 | Pacer Advisors Inc. | 5,513,230 | $435,325 | 12/31/2023 | CVS | 5,513,230 | $435,325 | 12/31/2023 | Wells Fargo & Company MN | | $405,445 | 12/31/2023 | CVS | 5,459,918 | $431,115 | 12/31/2023 | Put | 325,100 | $25,670 | 12/31/2023 | Marshall Wace LLP | 4,846,421 | $382,673 | 12/31/2023 | CVS | 4,846,421 | $382,673 | 12/31/2023 | Ameriprise Financial Inc. | 4,741,761 | $375,588 | 12/31/2023 | CVS | 4,741,761 | $375,588 | 12/31/2023 | Amundi | 4,375,514 | $351,616 | 12/31/2023 | CVS | 4,375,514 | $351,616 | 12/31/2023 | AQR Capital Management LLC | 4,410,651 | $348,265 | 12/31/2023 | CVS | 4,410,651 | $348,265 | 12/31/2023 | Citadel Advisors LLC | | $339,714 | 12/31/2023 | Call | 4,833,300 | $381,637 | 12/31/2023 | Put | 2,179,300 | $172,078 | 12/31/2023 | CVS | 1,648,370 | $130,155 | 12/31/2023 | Harris Associates L P | 4,160,652 | $328,525 | 12/31/2023 | CVS | 4,160,652 | $328,525 | 12/31/2023 | Swiss National Bank | 4,016,360 | $317,132 | 12/31/2023 | CVS | 4,016,360 | $317,132 | 12/31/2023 | Barclays PLC | | $309,027 | 12/31/2023 | CVS | 4,291,423 | $338,851 | 12/31/2023 | Put | 645,300 | $50,953 | 12/31/2023 | Call | 267,600 | $21,129 | 12/31/2023 | Nuveen Asset Management LLC | 3,809,794 | $300,821 | 12/31/2023 | CVS | 3,809,794 | $300,821 | 12/31/2023 | Sumitomo Mitsui Trust Holdings Inc. | 3,734,320 | $297,849 | 03/31/2024 | CVS | 3,734,320 | $297,849 | 03/31/2024 | Primecap Management Co. CA | 3,443,795 | $271,922 | 12/31/2023 | CVS | 3,443,795 | $271,922 | 12/31/2023 | Susquehanna International Group LLP | | $261,071 | 12/31/2023 | Call | 5,008,500 | $395,471 | 12/31/2023 | Put | 2,246,000 | $177,344 | 12/31/2023 | CVS | 543,873 | $42,944 | 12/31/2023 | Two Sigma Advisers LP | 3,205,000 | $253,067 | 12/31/2023 | CVS | 3,205,000 | $253,067 | 12/31/2023 | Barrow Hanley Mewhinney & Strauss LLC | 3,195,930 | $252,351 | 12/31/2023 | CVS | 3,195,930 | $252,351 | 12/31/2023 | Bridgewater Associates LP | 3,054,404 | $241,176 | 12/31/2023 | CVS | 3,054,404 | $241,176 | 12/31/2023 | Clearbridge Investments LLC | 3,046,216 | $240,529 | 12/31/2023 | CVS | 3,046,216 | $240,529 | 12/31/2023 |
See All: Funds Holding CVS
See Details: Top 10 Hedge Funds Holding CVS
Also See: CVS Insider Buying
Also See: CVS Holdings Changes
Analysts Forecast: CVS Health Price Target
|
|